Attempting to self-administer an unlicensed substance without medical supervision is potentially dangerous and may also delay access to safe, effective, and evidence-based treatments that are already available
While not FDA-approved for type 1 diabetes (T1D), a growing number of people in the community are using them off-label to smooth out glucose levels, reduce post-meal spikes, and cut their total daily insulin needs
Go to the Appendix for more details
Psychiatry 9 , 173184 (2015)
Elevated blood pressure readings are something that can be misunderstood by physicians, since they dont think of it in the context of dental procedures
Although the FDA officially removed tirzepatide from the shortage list in December 2024 and semaglutide in February 2025, compounded prescribing has not abated